December 16, 2025 11:32 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Centre moves to replace MGNREGA with 'G Ram G', sets stage for winter session showdown | Messi surrounded by VIPs, fans rage: Five held in stadium vandalism case | 'Messi was uncomfortable, lost his cool!': Ex-India footballer reveals what really happened at chaotic Kolkata stadium | PM Modi embarks on historic three-nation visit to Jordan, Ethiopia, and Oman | Caught in Thailand! Fugitive Goa nightclub owners detained after deadly fire kills 25 | After Putin’s blockbuster Delhi visit, Modi set to host German Chancellor Friedrich Merz in January | Delhi High Court slams govt, orders swift compensation as IndiGo crisis triggers fare shock and nationwide chaos | Amazon drops a massive $35 billion India bet! AI push, 1 million jobs and big plans revealed at Smbhav Summit | IndiGo’s ‘All OK’ claim falls apart! Govt slaps 10% flight cut after weeklong chaos | Centre finally aligns IndiGo flights with airline's operating ability, cuts its winter schedule by 5%
Adar Poonawalla | Covid vaccine
Image Credit: Adar Poonawalla Twitter

Vaccine hesitancy is now the greatest threat in overcoming pandemic: Adar Poonawalla

| @indiablooms | Nov 18, 2021, at 06:04 am

New Delhi/IBNS:  Serum Institute of India chief Adar Poonawalla, whose pharma company manufactured COVID-19 vaccine Covishield, on Wednesday said the hesitancy to get inoculated is the "greatest threat" in overcoming the pandemic.

Urging all those eligible to get vaccinated as soon as possible, Poonawalla said there are "over 200 million doses" of Covishield vaccine available with states.

"The vaccine industry has worked tirelessly to provide enough stocks for the nation. Today there are over 200 million doses available with states. I urge all adults to get vaccinated as soon as possible. Vaccine hesitancy is now the greatest threat in overcoming this pandemic," he said in a tweet.

AstraZeneca and Oxford University developed  Covishield and Bharat Biotech's Covaxin are the two widely used vaccines against COVID-19 in India.

India’s COVID-19 vaccination coverage has crossed 114 crore landmark milestone on Wednesday, the Centre informed in its late night bulletin.

"More than 65 lakh (65,73,687) Vaccine Doses have been administered till 7 pm today.  The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight," the statement read.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.